The inside story from Aspen on Covid-19 Dexamethasone: MUST LISTEN

Loading player...
This week, the world woke up to the exciting news that Dexamethasone, a cheap drug in the Aspen stable, dramatically improves the chances of survival for people seriously ill in hospitals with Covid-19. The Aspen share price has jumped up in value on the Johannesburg stock exchange as investors anticipate high demand for Dexamethasone. In this interview with BizNews founder Alec Hogg, Aspen group senior executive Stavros Nicolaou shares the details of what is known about Dexamethasone and how it will be made available. Learn more about your ad choices. Visit megaphone.fm/adchoices
17 Jun 2020 2PM English South Africa Investing · Business News

Other recent episodes

How solidarity plans to force out BEE by 2030: Connie Mulder | The NdB Sunday Show

In this edition of the NdB Sunday Show with Chris Steyn, Connie Mulder, the head of Solidarity's Research Institute (SRI) shares its comprehensive roadmap to gradually transition South Africa from race-based legislation to real empowerment, based on need, economic growth and job creation by 2030. It includes practical suggestions on…
17 May 7AM 30 min

How Egoli Youth Empowerment turned squash into a pathway to opportunity for Joburg's youth

Egoli Youth Empowerment started with squash courts in Soweto and grew into a holistic youth development programme spanning sport, academic support, life skills, leadership, entrepreneurship and urban farming. Director Glenn Lazarus and Programme Director Sharon Sibanda tell BizNews how EYE is creating safe spaces, developing young talent, and helping vulnerable…
15 May 9AM 19 min